Biohaven Pharmaceutical Holding Company Ltd. Stock
Equities
BHVN
VGG111961055
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
33.81 USD | +1.26% | -11.99% | -78.00% |
May. 31 | Biohaven Insider Bought Shares Worth $996,240, According to a Recent SEC Filing | MT |
May. 15 | Biohaven Insider Bought Shares Worth $512,877, According to a Recent SEC Filing | MT |
Financials (USD)
Sales 2020 | 63.63 | Sales 2021 | 462.51 | Capitalization | 9.03B |
---|---|---|---|---|---|
Net income 2020 | -767M | Net income 2021 | -847M | EV / Sales 2020 | 87,534,473 x |
Net Debt 2020 | 432M | Net Debt 2021 | 860M | EV / Sales 2021 | 21,377,123 x |
P/E ratio 2020 |
-6.56
x | P/E ratio 2021 |
-10.5
x | Employees | 928 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 90.13% |
1 day | -3.47% | ||
Current month | -78.00% | ||
Current year | -78.00% |
Managers | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Jon Blaskovich
CTO | Chief Tech/Sci/R&D Officer | - | - |
Compliance Officer | - | 17-10-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paloma Moraleda
PSD | President | - | 22-10-02 |
Gastón Ortega
BRD | Director/Board Member | - | 22-10-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.97% | 0 M€ | 0.00% | - | |
0.11% | 9 M€ | -.--% | - | |
0.06% | 744 M€ | +9.10% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 33.39 | 0.00% | 78 163 |
24-06-04 | 33.39 | -3.47% | 746,477 |
24-06-03 | 34.59 | -1.37% | 1,232,648 |
24-05-31 | 35.07 | -0.45% | 1,399,398 |
24-05-30 | 35.23 | +6.21% | 1,999,508 |
Delayed Quote Nyse, June 04, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-78.00% | 541M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.84% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- BHVN Stock